Schroder Investment Management Group Biomarin Pharmaceutical Inc Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 129,449 shares of BMRN stock, worth $8.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

129,449

Previous 229,599 43.62%

Holding current value

$8.58 Million

Previous $18.9 Million 51.87%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $6.91 Million - $9.4 Million	-100,150 Reduced 43.62%	129,449 $9.1 Million
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $1.53 Million - $1.89 Million	-20,494 Reduced 8.19%	229,599 $18.9 Million
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $1.7 Million - $2.01 Million	-20,324 Reduced 7.52%	250,093 $21.8 Million
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $10.8 Million - $14 Million	141,694 Added 110.08%	270,417 $26.1 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $857,675 - $952,547	-10,082 Reduced 7.26%	128,723 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $91,360 - $105,716	-1,054 Reduced 0.75%	138,805 $12 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $76,860 - $102,728	876 Added 0.63%	139,859 $13.6 Million
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $2.5 Million - $3.35 Million	30,867 Added 28.55%	138,983 $14.4 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $7.88 Million - $9.3 Million	95,959 Added 789.33%	108,116 $9.17 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $371,267 - $451,098	5,194 Added 74.59%	12,157 $1.01 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $151,605 - $189,180	2,041 Added 41.47%	6,963 $542,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $6,813 - $8,689	95 Added 1.97%	4,922 $435,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $21,159 - $24,188	-283 Reduced 5.54%	4,827 $373,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $88,346 - $99,204	1,170 Added 29.7%	5,110 $427,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $5,754 - $6,983	77 Added 1.99%	3,940 $298,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $5,663 - $7,035	-78 Reduced 1.98%	3,863 $338,000
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $24,579 - $44,812	-342 Reduced 7.99%	3,941 $295,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $42,559 - $66,457	-535 Reduced 11.1%	4,283 $528,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $343,860 - $466,623	4,818 New	4,818 $398,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Biomarin Pharmaceutical Inc Transaction History